Home > Financial Ratios > ALKEM LABORATORIES

ALKEM LABORATORIES
Core EBITDA Growth

    Back to All Ratios
ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for ALKEM LABORATORIES
Please provide your vote to see the results

ALKEM LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.5940.03-17.601.8437.90

What is the latest Core EBITDA Growth ratio of ALKEM LABORATORIES ?

The latest Core EBITDA Growth ratio of ALKEM LABORATORIES is 17.59 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.59
Mar202440.03
Mar2023-17.60
Mar20221.84
Mar202137.90

How is Core EBITDA Growth of ALKEM LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 17.59
-56.06
Mar2024 40.03
Positive
Mar2023 -17.6
Negative
Mar2022 1.84
-95.15
Mar2021 37.9 -

Other Financial Ratios of ALKEM LABORATORIES


Compare Core EBITDA Growth ratio of peers of ALKEM LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALKEM LABORATORIES ₹67,960.3 Cr 1% 5.2% 15.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹470,786.0 Cr 0.8% 7.3% 15.6% Stock Analytics
DIVIS LABORATORIES ₹194,590.0 Cr 1.9% 8.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,658.0 Cr 0.6% 12.6% 43.9% Stock Analytics
CIPLA ₹115,728.0 Cr 0.2% 6.3% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,708.0 Cr -1.8% -3.5% -3.4% Stock Analytics


ALKEM LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALKEM LABORATORIES

1%

5.2%

15.5%

SENSEX

0.5%

0.1%

-6.1%


You may also like the below Video Courses